Archive for September, 2007

SPOTLIGHT: India focuses on biosimilars

Posted by smaranya on 25th September , 2007

India sees a big future for itself in biogenerics. Wockhardt, Dr Reddy’s Lab, Biocon, Sun Pharma, Shanta Biotech, Panacea Biotech and Ranbaxy Lab are all initiating programs Read more…
Original post by admin

Manufacturing is dead. Long live manufacturing!

Posted by smaranya on 18th September , 2007

On the same day that AstraZeneca has announced that it intents to completely outsource all of its drug manufacturing, citing the prevalence of external parties who can do it better and cheaper, Sanofi has announced plans toIf you understand the rules and strategies of free blackajck online it won’t be difficult for you. increase [...]

Upcoming events

Posted by smaranya on 17th September , 2007

I’ll be attending the Mid-Atlantic Bio in Bethesda in late October.
On November 8th I’ll be in Turkey speaking at the Biotechnology for Turkey Conference.
I’ll be in Toronto in late November, speaking in the AstraZeneca speaker series at the University of Toronto.
If you’re interested in more details or want to meet up, drop me a [...]

ALSO NOTED: FDA approves MedPointe’s SOMA; EntreMed secures $20M loan; and much more…

Posted by smaranya on 17th September , 2007

> The FDA has approved MedPointe’s SOMA (carisoprodol) 250 mg as a new recommended dose for the relief of discomfort associated with acute, painful musculoskeletal conditions, such as backache.

Building Biotechnology on Facebook

Posted by smaranya on 7th September , 2007

With the start of a new school year, a new cohort of students are entering biotechnology programs. In order to facilitate those who are using my book, Building Biotechnology, I have set up a networking and information group on facebook.
I’m always interested in tracking the outcomes of students in biotechnology programs. If you’re [...]

Drug Patent Expirations in September 2007

Posted by smaranya on 4th September , 2007

Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in September 2007*Drugs may be covered by more than one patent

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration

BETAXON
Alcon
levobetaxolol hydrochloride
4,911,920
SEP 27,2007

BETOPTIC S
Alcon
betaxolol hydrochloride
4,911,920
SEP 27,2007

CARDIOLITE
Bristol Myers Squibb
technetium tc-99m sestamibi kit
4,885,100
SEP 11,2007

COGNEX
Sciele Pharma Inc
tacrine hydrochloride
4,816,456
SEP 09,2007

COREG
Smithkline Beecham
carvedilol
4,503,067
SEP 05,2007

COREG CR
Sb Pharmco
carvedilol phosphate
4,503,067
SEP 05,2007

MIRALUMA
Bristol Myers Squibb
technetium tc-99m sestamibi kit
4,885,100
SEP 11,2007

NEXIUM
Astrazeneca
esomeprazole magnesium
4,738,974
SEP 01,2007

PENLAC
Sanofi Aventis Us
ciclopirox
4,957,730
SEP 18,2007

PULMICORT
Astrazeneca
budesonide
4,907,583
SEP 13,2007

TECZEM
Biovail
diltiazem malate; enalapril [...]

AstraZeneca eyes rapid expansion of China trials

Posted by smaranya on 4th September , 2007

AstraZeneca has struck a deal with Peking University that will swiftly expand the number of early-stage clinical trials underway in China. AstraZeneca is looking for a much greater involvement in Read more…
Original post by admin